4 Recruiting Recurrent B Acute Lymphoblastic Leukemia Phase 1 Clinical Trials
Active phase 1 studies for recurrent b acute lymphoblastic leukemia enrolling across the USA. Verify eligibility and contact site coordinators.
All Recurrent B Acute Lymphoblastic Leukemia studiesPhase 1 Studies for Recurrent B Acute Lymphoblastic Leukemia
🔵 Active, Not Recruiting Phase1
Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia
📍 Yale University — New Haven, Connecticut
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase1
Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase1
Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma
📍 University of Michigan Rogel Cancer Center — Ann Arbor, Michigan
View Study & Checklist ➔ 🟢 Recruiting Phase1
Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukemia
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔